Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only...
FDA Drug Recall #D-0102-2025 — Class III — November 14, 2024
Recall Summary
| Recall Number | D-0102-2025 |
| Classification | Class III — Low risk |
| Date Initiated | November 14, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Zydus Pharmaceuticals (USA) Inc |
| Location | Pennington, NJ |
| Product Type | Drugs |
| Quantity | 4404 packs |
Product Description
Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94. Packaged in sachets
Reason for Recall
Labeling: Not Elsewhere Classified - Wrong NDC number
Distribution Pattern
USA Nationwide.
Lot / Code Information
Lot#: M408002, Exp 05/31/2026
Other Recalls from Zydus Pharmaceuticals (USA) Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0544-2026 | Class II | Erythromycin Tablets, USP, 250 mg, 30 tablets p... | Apr 29, 2026 |
| D-0545-2026 | Class II | Erythromycin Tablets, USP, 500 mg, 30 tablets p... | Apr 29, 2026 |
| D-0400-2026 | Class II | Icosapent Ethyl Capsules, 1 gram, 120 Capsules ... | Mar 9, 2026 |
| D-0295-2026 | Class II | Icosapent Ethyl capsules, 1 gram, 120-count bot... | Dec 30, 2025 |
| D-0247-2026 | Class III | traZODONE Hydrochloride Tablets, USP, 100mg, 1,... | Dec 19, 2025 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.